Open AccessMTHFR C677 T gene polymorphism in lymphoproliferative diseases
Author(s) -
Deligezer Ugur,
Akisik Ebru E.,
Yaman Fulya,
Erten Nilgün,
Dalay Nejat
Publication year - 2006
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.20103
Subject(s) - methylenetetrahydrofolate reductase , genotype , allele , lymphoproliferative disorders , lymphoma , medicine , gastroenterology , allele frequency , gene polymorphism , biology , immunology , gene , genetics
Methylenetetrahydrofolate reductase ( MTHFR ), a key enzyme in folate metabolism, has been implicated in cancer risk. In the present study we used a melting curve analysis to investigate the association of the common MTHFR C677 T polymorphism with lymphoproliferative diseases. Patients (n=117) were compared with age‐ and sex‐matched control subjects (n = 154). Our results indicate that the 677 T variant occurred less frequently in patients (26%) than in the control group (33.7%; P= 0.05). Investigation of the variant allele (677 T) frequency in the subgroups with Hodgkin's lymphoma (HL) and B‐cell neoplasms (BCNs) revealed that this difference was a result of the significantly lower distribution of the variant allele in patients with HL (20.5%; P= 0.01). This was accompanied by a significantly higher frequency of the homozygote normal genotype (677CC) among the patients with HL. In patients with BCNs the distribution of the variant allele (30.3%) was comparable to that in the control group ( P= 0.47). However, the difference between HL (20.5%) and BCNs (30.3%) did not reach statistical significance ( P= 0.09). Our results suggest that the distribution of the C677 T polymorphism may vary among lymphoproliferative diseases. J. Clin. Lab. Anal. 20:37–41, 2006. © 2006 Wiley‐Liss, Inc.